Integrating the Patient’s Voice into the Research Agenda for Treatment of Chemosensory Disorders
Chemical Senses · 2024
DOI: 10.1093/chemse/bjae020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Senses, 2024. Verfasst von Claire Murphy und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, San Diego State University, San Diego, CA, United States. Hauptthemen laut MEDLINE: Olfaction Disorders, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCD NIH HHS, NIA NIH HHS, NIH HHS.
Abstract (Originalsprache)
World-wide some 658 million people were infected with COVID-19 and millions suffer from chemosensory impairment associated with long COVID. Current treatments for taste and smell disorders are limited. Involving patients has the potential to catalyze the dynamic exchange and development of new ideas and approaches to facilitate biomedical research and therapeutics. We assessed patients’ perceptions of the efficacy of treatments for chemosensory impairment using an online questionnaire completed by 5,815 people in the U.S. Logistic regression determined variables predictive of reported treatment efficacy for patients aged 18-24, 25-39, 40-60 and 60+ yrs. who were treated with nasal steroids, oral steroids, zinc, nasal rinse, smell training, theophylline, platelet rich plasma, and Omega 3. The most consistent predictor was age, with the majority of those 40-60 and 60+ reporting that nasal steroids, oral steroids, zinc, nasal rinse and smell training were only slightly effective or not effective at all. Many of these treatment strategies target regeneration and immune response, processes compromised by age. Only those under 40 reported more than slight efficacy of steroids or smell training. Findings emphasize the need to include patients of all ages in clinical trials. Older adults with olfactory impairment are at increased risk for Alzheimer’s disease (AD). We speculate that olfactory impairment associated with long COVID introduces the potential for a significant rise in AD. Long COVID-associated chemosensory impairment increases the urgency for translational and clinical research on novel treatment strategies. Suggestions for high priority areas for epidemiological, basic, and clinical research on chemosensory impairment follow.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychology, San Diego State University, San Diego, CA, United States.
- Department of Psychiatry, University of California, San Diego, CA, United States.
- Monell Chemical Senses Center, Philadelphia, A, United States.
- The Smell and Taste Association of North America, Philadelphia, PA, United States.
- Monell Chemical Senses Center, Philadelphia, PA, United States.
- ExPPect, LLC, Arlington, VA, United States.
ORCID-Profile: Claire Murphy, Pamela Dalton, Katie Boateng, Stephanie Hunter, Pamela Silberman, Jenifer Trachtman, Suz Schrandt, Bita Naimi, Emily Garvey, Paule V Joseph, Conner Frank, Abigail Albertazzi, Gurston Nyquist, Nancy E Rawson
Förderung
- NIDCD NIH HHS
- NIA NIH HHS
- NIH HHS
Zitieren
APA
Murphy, C., Dalton, P., Boateng, K., Hunter, S., Silberman, P., Trachtman, J., Schrandt, S., Naimi, B., Garvey, E., Joseph, P. V., Frank, C., Albertazzi, A., Nyquist, G., & Rawson, N. E. (2024). Integrating the Patient’s Voice into the Research Agenda for Treatment of Chemosensory Disorders. Chemical Senses. https://doi.org/10.1093/chemse/bjae020
Vancouver
Murphy C, Dalton P, Boateng K, Hunter S, Silberman P, Trachtman J, et al. Integrating the Patient’s Voice into the Research Agenda for Treatment of Chemosensory Disorders. Chemical Senses. 2024. doi:10.1093/chemse/bjae020
BibTeX
@article{Murphy2024,
author = {Murphy, Claire and Dalton, Pamela and Boateng, Katie and Hunter, Stephanie and Silberman, Pamela and Trachtman, Jenifer and Schrandt, Suz and Naimi, Bita and Garvey, Emily and Joseph, Paule V and Frank, Conner and Albertazzi, Abigail and Nyquist, Gurston and Rawson, Nancy E},
title = {Integrating the Patient’s Voice into the Research Agenda for Treatment of Chemosensory Disorders},
journal = {Chemical Senses},
year = {2024},
doi = {10.1093/chemse/bjae020}
}
EUVIMED